C85.98 Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites

Name of the Condition

• Common Name: Non-Hodgkin Lymphoma
• Medical Term: Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites
• ICD Code: C85.98

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that affect the lymphatic system, part of the immune system. This code is used when the specific subtype of NHL is not clearly defined and the lymphoma is located in lymph nodes of multiple sites. The lymphatic system helps fight infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes in multiple areas (e.g., neck, armpits, groin)
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Abdominal pain or swelling
• Persistent cough or chest discomfort
• Itching or skin rashes

Diagnosis

Diagnosis typically involves a combination of physical examination, blood tests, imaging scans (CT, MRI, PET), and lymph node biopsy. A biopsy confirms the presence of cancerous lymphocytes and helps determine the subtype, while imaging assesses the extent of disease spread.

Treatment Options

• Chemotherapy: Uses drugs to destroy cancer cells.
• Radiation therapy: Targets specific areas to reduce tumor size.
• Immunotherapy: Boosts the immune system to fight cancer.
• Stem cell transplant: Replaces damaged bone marrow with healthy cells.
• Targeted therapy: Blocks specific molecules involved in cancer growth.

Prognosis and Follow-Up

Prognosis depends on factors like age, overall health, and disease stage. Regular follow-up appointments monitor for recurrence or complications. Treatment response and long-term survival rates vary based on individual circumstances.

Complications

• Infection due to weakened immune system
• Anemia or bleeding disorders
• Organ damage from tumor growth
• Treatment-related side effects (e.g., fatigue, nausea)
• Increased risk of secondary cancers

Lifestyle & Prevention

• Maintain a balanced diet and regular exercise to support immune health.
• Avoid exposure to known carcinogens (e.g., pesticides, tobacco).
• Practice good hygiene to reduce infection risk.
• Stay up-to-date with vaccinations (as recommended by a healthcare provider).

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or night sweats. Early evaluation is important for timely diagnosis and treatment.

Tips for Medical Coders

This code (C85.98) is used when non-Hodgkin lymphoma is unspecified and involves lymph nodes of multiple sites. Ensure documentation supports the unspecified subtype and multi-site lymph node involvement. Verify that more specific codes are not applicable before assigning this code.